Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) released yesterday morning the FDA’s decision approving the firm’s pipeline drug Iclusig (ponatinib), used in the treatment of chronic …
OvaScience Inc (NASDAQ:OVAS) just reported second-quarter earnings, but for JMP Securities analyst Michael King, the true assessment of OVAS as an investing opportunity …
